Global Gram-Negative Bacterial Infection Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4916387
- 88 Pages
- March 2022
- Medical Devices
The United States Gram-Negative Bacterial Infection Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gram-Negative Bacterial Infection Therapeutics market, reaching US$ million by the year 2028. As for the Europe Gram-Negative Bacterial Infection Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gram-Negative Bacterial Infection Therapeutics players cover Baxter, Sanofi, GlaxoSmithKline, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gram-Negative Bacterial Infection Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Enteral Treatment
Parenteral Treatment
Topical Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Baxter
Sanofi
GlaxoSmithKline
Novartis
Pfizer
Takeda
Nektar Therapeutics
Sumitomo
Targeted Genetics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size 2017-2028
2.1.2 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gram-Negative Bacterial Infection Therapeutics Segment by Type
2.2.1 Enteral Treatment
2.2.2 Parenteral Treatment
2.2.3 Topical Treatment
2.3 Gram-Negative Bacterial Infection Therapeutics Market Size by Type
2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Gram-Negative Bacterial Infection Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Gram-Negative Bacterial Infection Therapeutics Market Size by Application
2.5.1 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2017-2022)
3 Gram-Negative Bacterial Infection Therapeutics Market Size by Player
3.1 Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Players
3.1.1 Global Gram-Negative Bacterial Infection Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gram-Negative Bacterial Infection Therapeutics by Regions
4.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2017-2022)
4.3 APAC Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2017-2022)
4.4 Europe Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2017-2022)
5.2 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022)
5.3 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2017-2022)
6.2 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022)
6.3 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gram-Negative Bacterial Infection Therapeutics by Country (2017-2022)
7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022)
7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.1 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.3 APAC Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.4 Europe Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Forecast
10.2 Americas Gram-Negative Bacterial Infection Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.2.2 Canada Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.2.3 Mexico Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.2.4 Brazil Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3 APAC Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2023-2028)
10.3.1 China Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.2 Japan Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.3 Korea Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.4 Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.5 India Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.6 Australia Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.4 Europe Gram-Negative Bacterial Infection Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.4.2 France Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.4.3 UK Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.4.4 Italy Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.4.5 Russia Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.5.2 South Africa Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.5.3 Israel Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.5.4 Turkey Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.5.5 GCC Countries Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.6 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Type (2023-2028)
10.7 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Gram-Negative Bacterial Infection Therapeutics Product Offered
11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Baxter Main Business Overview
11.1.5 Baxter Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offered
11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offered
11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Gram-Negative Bacterial Infection Therapeutics Product Offered
11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offered
11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Takeda
11.6.1 Takeda Company Information
11.6.2 Takeda Gram-Negative Bacterial Infection Therapeutics Product Offered
11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Takeda Main Business Overview
11.6.5 Takeda Latest Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Information
11.7.2 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offered
11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Nektar Therapeutics Main Business Overview
11.7.5 Nektar Therapeutics Latest Developments
11.8 Sumitomo
11.8.1 Sumitomo Company Information
11.8.2 Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offered
11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sumitomo Main Business Overview
11.8.5 Sumitomo Latest Developments
11.9 Targeted Genetics
11.9.1 Targeted Genetics Company Information
11.9.2 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offered
11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Targeted Genetics Main Business Overview
11.9.5 Targeted Genetics Latest Developments
12 Research Findings and Conclusion
Table 1. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Enteral Treatment
Table 3. Major Players of Parenteral Treatment
Table 4. Major Players of Topical Treatment
Table 5. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Products Offered
Table 14. Gram-Negative Bacterial Infection Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Gram-Negative Bacterial Infection Therapeutics
Table 44. Key Market Challenges & Risks of Gram-Negative Bacterial Infection Therapeutics
Table 45. Key Industry Trends of Gram-Negative Bacterial Infection Therapeutics
Table 46. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Baxter Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 53. Baxter Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 54. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Baxter Main Business
Table 56. Baxter Latest Developments
Table 57. Sanofi Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 58. Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Sanofi Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 63. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Novartis Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 68. Novartis Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis Latest Developments
Table 72. Pfizer Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 73. Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 74. Pfizer Main Business
Table 75. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Pfizer Latest Developments
Table 77. Takeda Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 78. Takeda Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 79. Takeda Main Business
Table 80. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Takeda Latest Developments
Table 82. Nektar Therapeutics Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 83. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 84. Nektar Therapeutics Main Business
Table 85. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Nektar Therapeutics Latest Developments
Table 87. Sumitomo Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 88. Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 89. Sumitomo Main Business
Table 90. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Sumitomo Latest Developments
Table 92. Targeted Genetics Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 93. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 94. Targeted Genetics Main Business
Table 95. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Targeted Genetics Latest Developments
List of Figures
Figure 1. Gram-Negative Bacterial Infection Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type in 2021
Figure 7. Gram-Negative Bacterial Infection Therapeutics in Hospitals
Figure 8. Global Gram-Negative Bacterial Infection Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Gram-Negative Bacterial Infection Therapeutics in Clinics
Figure 10. Global Gram-Negative Bacterial Infection Therapeutics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Gram-Negative Bacterial Infection Therapeutics in Others
Figure 12. Global Gram-Negative Bacterial Infection Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Gram-Negative Bacterial Infection Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Gram-Negative Bacterial Infection Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Gram-Negative Bacterial Infection Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Gram-Negative Bacterial Infection Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Gram-Negative Bacterial Infection Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
